首页> 外国专利> FUSED COMPOUNDS CONTAINING AN UREIDO GROUP THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ,FOR TREATING DISORDERS CAUSED BY VANILLOID RECEPTOR ACTIVITY AND PROCESS FOR THEIR PREPARATION

FUSED COMPOUNDS CONTAINING AN UREIDO GROUP THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ,FOR TREATING DISORDERS CAUSED BY VANILLOID RECEPTOR ACTIVITY AND PROCESS FOR THEIR PREPARATION

机译:包含尿素基团的融合化合物,可抑制香草醛受体亚型1(VR1)受体,用于治疗香草醛受体活性及其制备方法引起的疾病

摘要

The present invention discloses novel compounds of general formula (I), or a pharmaceutically acceptable salt thereof (in which X 1 - X 5 , R 5 - R 8b , Z 1 - Z 2 and Ar 1 are defined herein), pharmaceutical compositions including those compounds and a process for making those compounds. The compounds of formula (I) are useful for treating pain, bladder overreactivity, urinary incontinence, inflammatory hyperalgesia by inhibiting the VR1 receptor in mammals.
机译:本发明公开了通式(I)的新型化合物或其药学上可接受的盐(其中X 1 -X 5,R 5 -R 8b,Z 1 -Z 2和Ar 1在本文中定义),药物组合物包括这些化合物以及制备这些化合物的方法。通过抑制哺乳动物中的VR1受体,式(I)化合物可用于治疗疼痛,膀胱过度反应,尿失禁,炎性痛觉过敏。

著录项

  • 公开/公告号IL215997D0

    专利类型

  • 公开/公告日2011-12-29

    原文格式PDF

  • 申请/专利权人 ABBOTT LABORATORIES;

    申请/专利号IL20110215997

  • 发明设计人

    申请日2011-10-27

  • 分类号A61P13/10;C07D;C07D217/02;C07D231/56;C07D401/12;C07D403/12;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号